In recent months, Linda has also collaborated with medical professionals like Dr. William Lawson to provide expert-led sessions that explore the intersection of communication and mental health treatment. One such session focused on Gabapentin, a medication commonly prescribed for nerve-related conditions and sometimes used off-label for mood disorders. Dr. Lawson emphasized the importance of clear, stigma-free communication between providers and patients when discussing such treatments. Linda complemented his insights by demonstrating how nonverbal cues can reinforce trust and reduce anxiety during sensitive consultations. This dialogue highlighted the shared responsibility of medical and communication professionals in improving treatment adherence. As more patients seek clarity about medications like Gabapentin, the need for compassionate, informed conversations continues to grow. Linda remains committed to fostering those conversations across industries.
